Partner Content Ability to Treat Diabetic Patients: With a Novel Combined DES and DCB in a Single Platform - Concept Medical November 4, 2019
Video » Interview Dr. C. Michael Gibson Talks With Dr. Dean Kereiakis About the First Human Use of a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor (RUC-4) Designed for STEMI Point of Care Treatment September 26, 2019
Partner Content Ultrathin Orsiro DES: Novel technology, eye-catching cases and robust evidence March 7, 2019